World is running out of antibiotics: WHO
Antibiotics that are currently in clinical development are insufficient to combat the growing threat of antimicrobial resistance, as stated by World Health Organisation (WHO) report.
Most of the drugs currently in the clinical phase are modifications of existing classes of antibiotics and are only short-term solutions.
There are, however, very few potential treatment options. The growing resistant infections pose the greatest threat to health, including drug-resistant tuberculosis (TB) which kills around 250,000 people each year. There are also very few oral antibiotics in the pipeline, yet these are essential formulations for treating infections outside hospitals or in resource-limited settings.
Besides TB, the WHO has also identified 12 classes of priority pathogens, including common infections like pneumonia or urinary tract infections that are increasingly resistant to existing antibiotics and urgently in need of new treatments.
Among the newly identified 51 new antibiotics and biologicals in clinical development, only eight are classed by WHO as innovative treatments that will add value to the current antibiotic treatment arsenal.